The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis
Open accessAbstract
BACKGROUND: Esophageal cancer is the sixth leading cause of cancer-related deaths and the eighth most common cancer worldwide with a 5-year survival rate of less than 25%. Here we report the incidence, risk factors and treatment options that are available currently, and moving into the future. METHODS: We retrospectively analyzed the Surveillance Epidemiology and End Results (SEER) database made available by the National Cancer Institute in the USA. Specifically we extracted data from the years 2004 - 2015. RESULTS: In total we identified 23,804 patients with esophageal adenocarcinoma and 13,919 patients with esophageal squamous cell carcinoma. Males were at an increased risk of developing both types of esophageal cancer when compared to females. Most cases of adenocarcinoma were diagnosed as poorly differentiated grade III (42%), and most cases of squamous cell carcinoma were diagnosed as moderately differentiated grade II (39.5%). The most common stage of presentation for both adenocarcinoma (36.9%) and squamous cell (26.8%) carcinoma was stage IV. The worst outcomes for adenocarcinoma were noted with grade III tumors (hazard ratio (HR): 1.56, 95% confidence interval (CI): 1.44 - 1.68, P value: < 0.01), stage IV tumors (HR: 3.58, 95% CI: 3.33 - 3.85, P value: < 0.01) and those not treated with surgery (HR: 2.54, 95% CI: 2.44 - 2.65, P value: < 0.01). For squamous cell carcinoma, the worst outcomes were noted with grade III tumors (HR: 1.35, 95% CI: 1.23 - 1.49, P value: < 0.01), stage IV tumors (HR: 2.12, 95% CI: 1.94 - 2.32, P value: <0.01). CONCLUSIONS: The incidence of esophageal adenocarcinoma in the USA is steadily on the rise. Conversely, the incidence of squamous cell carcinoma has been continually declining. While white males had an increased incidence of both types of esophageal cancer, a higher proportion of African Americans suffered from squamous cell carcinoma. Despite the wide spread use of proton pump inhibitors, adenocarcinoma continues to be a major public health concern.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Epidemiology of Esophageal Squamous Cell Carcinoma
Abnet, C. C., Arnold, M., & Wei, W.-Q. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.08.023 · Cited by 1,672
Sjoquist, K. M., Burmeister, B. H., Smithers, B. M., Zalcberg, J. R., Simes, R. J., Barbour, A., & Gebski, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70142-5 · Cited by 1,647
ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus
Shaheen, N. J., Falk, G. W., Iyer, P. G., & Gerson, L. B. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.322 · Cited by 1,501
Global incidence of oesophageal cancer by histological subtype in 2012
Arnold, M., Soerjomataram, I., Ferlay, J., & Forman, D. (2015) · Gut · doi:10.1136/gutjnl-2014-308124 · Cited by 1,423
Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries
Arnal, M. J. D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i26.7933 · Cited by 1,018
(2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.030 · Cited by 1,009
Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities
Napier, K. J. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i5.112 · Cited by 796
Current Cigarette Smoking Among Adults — United States, 2016
Jamal, A., Phillips, E., Gentzke, A. S., Homa, D. M., Babb, S. D., King, B. A., & Neff, L. J. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6702a1 · Cited by 737
The Epidemiology of Esophageal Adenocarcinoma
Coleman, H. G., Xie, S.-H., & Lagergren, J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.07.046 · Cited by 549
Current cigarette smoking among adults — United States, 2005–2014
Jamal, A., Homa, D. M., O’Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., Hu, S. S., & King, B. A. (2015) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6444a2 · Cited by 528
Prevalence of Barrett's esophagus in asymptomatic individuals
Gerson, L. B., Shetler, K., & Triadafilopoulos, G. (2002) · Gastroenterology · doi:10.1053/gast.2002.34748 · Cited by 448
Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A CostUtility Analysis
Inadomi, J. M., Sampliner, R., Lagergren, J., Lieberman, D., Fendrick, A. M., & Vakil, N. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00009 · Cited by 361
Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China
He, L., He, L., Jin-Hu, F., You-Lin, Q., Jin-Hu, F., & You-Lin, Q. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0093 · Cited by 359
Njei, B., McCarty, T. R., & Birk, J. W. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13289 · Cited by 351
Increasing incidence of Barrett's oesophagus in the general population
van Soest, E. M. (2005) · Gut · doi:10.1136/gut.2004.063685 · Cited by 319
Epidemiology of esophageal adenocarcinoma
Pera, M., Manterola, C., Vidal, O., & Grande, L. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20357 · Cited by 298
Screening for esophageal squamous cell carcinoma: recent advances
Codipilly, D. C., Qin, Y., Dawsey, S. M., Kisiel, J., Topazian, M., Ahlquist, D., & Iyer, P. G. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.04.2352 · Cited by 279
SEER (Surveillance, Epidemiology, and End Results Program)
Goodman, C. S. (1988) · Cited by 188
Polednak, A. P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11029 · Cited by 176
Increasing incidence of Barrett’s oesophagus: a population-based study
Coleman, H. G., Bhat, S. K., Murray, L., et al. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9596-z · Cited by 107
Global time trends in the incidence of esophageal squamous cell carcinoma
Wang, Q.-L., Xie, S., Wahlin, K., & Lagergren, J. (2018) · Clinical Epidemiology · doi:10.2147/clep.s166078 · Cited by 90
Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly
Abrams, J. A., Buono, D. L., Strauss, J. A., McBride, R. B., Hershman, D. L., & Neugut, A. I. (2009) · Cancer · doi:10.1002/cncr.24536 · Cited by 78
Incidence and survival differences in esophageal cancer among ethnic groups in the United States
Chen, Z., Ren, Y., Du, X. L., Yang, J., Shen, Y., Li, S., Wu, Y., Lv, M., Dong, D., Li, E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16694 · Cited by 57
Valmasoni, M., Pierobon, E. S., Ruol, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153068 · Cited by 18
Winker, M. A., & Lurie, S. J. (2009) · Oxford University Press eBooks · doi:10.1093/jama/9780195176339.021.285 · Cited by 17
Salcedo, J. D., Suen, S., & Bian, S. X. (2019) · Cancer Medicine · doi:10.1002/cam4.2721 · Cited by 6
Metadata
- Authors
- Then, E. O., Lopez, M., Saleem, S., Gayam, V., Sunkara, T., Culliford, A., & Gaduputi, V.
- Venue
- World Journal of Oncology
- Publisher
- Elmer Press, Inc.
- Published
- 2020
- Volume
- 11
- Issue
- 2
- Pages
- 55-64
- ISSN
- 1920-4531 (ISSN-L)
- 1920-454X
- OpenAlex
- W3013311028
- Cited by
- 332
- References
- 27
- FWCI
- 33.27
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.